EE433 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine
Abstract
Authors
DC Buse MT Driessen LJ Krasenbaum MJ Seminerio K Carr M Ortega E Packnett